Literature DB >> 14521195

Autism and specific language impairment: categorical distinction or continuum?

Dorothy V M Bishop1.   

Abstract

Traditionally, autism and specific language impairment (SLI) are regarded as distinct disorders, with differential diagnosis hinging on two features. First, in SLI one sees isolated language impairments in the context of otherwise normal development, whereas in autism a triad of impairments is seen, affecting communication, social interaction and behavioural repertoire. Second, there are different communication problems in these two conditions. Children with SLI have particular difficulty with structural aspects of language (phonology and syntax). In contrast, abnormal use of language (pragmatics) is the most striking feature of autism. However, recently, this conventional view has been challenged on three counts. First, children with autism have structural language impairments similar to those in SLI. Second, some children have symptoms intermediate between autism and SLT. Third, there is a high rate of language impairments in relatives of people with autism, suggesting aetiological continuities between SLI and autism. One interpretation of these findings is to regard autism as 'SLI plus', i.e. to assume that the only factor differentiating the disorders is the presence of additional impairments in autism. It is suggested that a more plausible interpretation is to regard structural and pragmatic language impairments as correlated but separable consequences of common underlying risk factors.

Entities:  

Mesh:

Year:  2003        PMID: 14521195

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  20 in total

1.  Autism and Cognition Within Epilepsy: Social Matters.

Authors:  Roberto Tuchman
Journal:  Epilepsy Curr       Date:  2015 Jul-Aug       Impact factor: 7.500

2.  Diagnostic differentiation of autism spectrum disorders and pragmatic language impairment.

Authors:  Lisa M Reisinger; Kim M Cornish; Eric Fombonne
Journal:  J Autism Dev Disord       Date:  2011-12

Review 3.  Do Children with Specific Language Impairment have a Cognitive Profile Reminiscent of Autism? A Review of the Literature.

Authors:  Lauren J Taylor; Murray T Maybery; Andrew J O Whitehouse
Journal:  J Autism Dev Disord       Date:  2012-10

Review 4.  Annual research review: re-thinking the classification of autism spectrum disorders.

Authors:  Catherine Lord; Rebecca M Jones
Journal:  J Child Psychol Psychiatry       Date:  2012-05       Impact factor: 8.982

5.  Absence of M100 source asymmetry in autism associated with language functioning.

Authors:  Gwenda L Schmidt; Michael M Rey; Janis E Oram Cardy; Timothy P L Roberts
Journal:  Neuroreport       Date:  2009-07-15       Impact factor: 1.837

6.  Cerebellum, language, and cognition in autism and specific language impairment.

Authors:  Steven M Hodge; Nikos Makris; David N Kennedy; Verne S Caviness; James Howard; Lauren McGrath; Shelly Steele; Jean A Frazier; Helen Tager-Flusberg; Gordon J Harris
Journal:  J Autism Dev Disord       Date:  2010-03

7.  Autism spectrum disorder scale scores in pediatric mood and anxiety disorders.

Authors:  Daniel S Pine; Amanda E Guyer; Michelle Goldwin; Kenneth A Towbin; Ellen Leibenluft
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-06       Impact factor: 8.829

8.  The broader language phenotype of autism: a comparison with specific language impairment.

Authors:  Andrew J O Whitehouse; Johanna G Barry; Dorothy V M Bishop
Journal:  J Child Psychol Psychiatry       Date:  2007-08       Impact factor: 8.982

Review 9.  Developmental language disorders: challenges and implications of cross-group comparisons.

Authors:  Susan Ellis Weismer
Journal:  Folia Phoniatr Logop       Date:  2013-08-12       Impact factor: 0.849

10.  A functional genetic link between distinct developmental language disorders.

Authors:  Sonja C Vernes; Dianne F Newbury; Brett S Abrahams; Laura Winchester; Jérôme Nicod; Matthias Groszer; Maricela Alarcón; Peter L Oliver; Kay E Davies; Daniel H Geschwind; Anthony P Monaco; Simon E Fisher
Journal:  N Engl J Med       Date:  2008-11-05       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.